Literature DB >> 3567152

Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation. Implications for diabetes mellitus.

J F Tarsio, L A Reger, L T Furcht.   

Abstract

The nonenzymatic glycation of basement membrane proteins, such as fibronectin and type IV collagen, occurs in diabetes mellitus. These proteins are nonenzymatically glycated in vivo and can also be nonenzymatically glycated in vitro. After 12 days of incubation at 37 degrees C with 500 mM glucose, purified samples of human plasma fibronectin and native type IV collagen showed a 13.0- and 4.2-fold increase, respectively, in glycated amino acid levels in comparison to control samples incubated in the absence of glucose. Gelatin (denatured calfskin collagen) was glycated 22.3-fold under the same conditions. Scatchard analyses were performed on the binding of radiolabeled fibronectin to gelatin or type IV collagen. It was found that there is a 3-fold reduction in the affinity of fibronectin to type IV collagen due to the nonenzymatic glycation of fibronectin. The dissociation constant (KD) for the binding of control fibronectin to type IV collagen was 9.6 X 10(-7) M while the KD for glycated fibronectin and type IV collagen was 2.9 X 10(-6) M. This was similar to the 2.7-fold reduction in the affinity of fibronectin for gelatin found as a result of the nonenzymatic glycation of fibronectin (KD of 4.5 X 10(-7) M for the interaction of control fibronectin with gelatin vs. KD of 1.2 X 10(-6) M for the interaction of nonenzymatically glycated fibronectin with gelatin). The molecular association of control fibronectin or its glycated counterpart with [3H]heparin was also determined. Scatchard analyses of this interaction showed no difference between control fibronectin and glycated fibronectin in [3H]heparin binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567152     DOI: 10.1021/bi00378a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Biochemical alterations in collagen IV induced by in vitro glycation.

Authors:  H M Raabe; H Molsen; S M Mlinaric; Y Açil; G H Sinnecker; H Notbohm; K Kruse; P K Müller
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Altered endothelin-1 induced contraction and second messenger generation in bovine retinal microvascular pericytes cultured in high glucose medium.

Authors:  U Chakravarthy; A McGinty; J McKillop; P Anderson; D B Archer; E R Trimble
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

Review 5.  Dynamic reciprocity in the wound microenvironment.

Authors:  Gregory S Schultz; Jeffrey M Davidson; Robert S Kirsner; Paul Bornstein; Ira M Herman
Journal:  Wound Repair Regen       Date:  2011 Mar-Apr       Impact factor: 3.617

6.  Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.

Authors:  J F Poduslo; G L Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction.

Authors:  Denise M McDonald; Gary Coleman; Ashay Bhatwadekar; Tom A Gardiner; Alan W Stitt
Journal:  Mol Vis       Date:  2009-08-05       Impact factor: 2.367

8.  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Authors:  H P Hammes; S Martin; K Federlin; K Geisen; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

9.  Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules.

Authors:  A J Bailey; T J Sims; N C Avery; C A Miles
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

10.  Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.

Authors:  Alexandra K Pastino; Todd M Greco; Rommel A Mathias; Ileana M Cristea; Jean E Schwarzbauer
Journal:  Matrix Biol       Date:  2016-07-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.